Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bromodomain PHD finger transcription factor (BPTF) is a large, multi-domain nuclear protein functioning as the central and largest subunit of the nucleosome-remodeling factor (NURF) complex, a key ATP-dependent chromatin remodeler[1][3][5]. BPTF contains a plant homeodomain (PHD) finger and a bromodomain, enabling it to read specific histone modifications such as H3K4me3 and H4K16ac[1][2][5]. Through its recognition of these epigenetic marks, BPTF facilitates nucleosome sliding and the modulation of chromatin structure, thereby controlling DNA accessibility and transcriptional activity[2][4][5]. BPTF is critical for early embryonic development, lineage specification, and tissue differentiation in mammals[1][2][4]. Genetic alteration or dysregulation of BPTF is implicated in various cancers, including melanoma, lung cancer, neuroblastoma, and bladder cancer, and its overexpression correlates with poor prognosis in several malignancies[2][5]. Additionally, high levels of the protein and certain isoforms have been detected in fetal brain and in neurodegenerative disease states[3][5]. The essential chromatin- and transcription-associated functions of BPTF, and its dysregulation in disease, make it a promising therapeutic target for the development of selective small-molecule inhibitors, though challenges remain due to its indispensability in normal development and tissue homeostasis[1][2].
Inhibition of chromatin association by blocking bromodomain or PHD finger interaction with acetylated or methylated histone tails Disruption of NURF complex formation or chromatin remodeling function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bromodomain PHD finger transcription factor (BPTF).